Between now and when we see something on the shelves, in my non-expert opinion, would be about three years. One year to design, carry out, and analyse the upcoming clinical trial, one year to get FDA approval, and another year to tool up, produce and distribute the product. I think that's a pretty optimistic timeline. That may sound terrible to some, but keep in mind, that is the beginning of OBJs entry into the pharmaceutical market. That is what is going to propel the company through the 2020's. In the meantime, we are going to be doing very well, i believe, in skin care and other areas.
- Forums
- ASX - By Stock
- WFL
- Ann: Clinical Trial for BodyGuard Technology
Ann: Clinical Trial for BodyGuard Technology, page-49
Featured News
Add WFL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online